Access Keys:
Skip to content (Access Key - 0)

Center for Cancer Research National Cancer Institute
Comparative Oncology Program

Comparative Oncology Trials Consortium

The Comparative Oncology Trials Consortium (COTC) is an active network of twenty academic comparative oncology centers, centrally managed by the NIH-NCI-Center for Cancer Research's Comparative Oncology Program, that functions to design and execute clinical trials in dogs with cancer to assess novel therapies. The goal of this effort is to answer biological questions geared to inform the development path of these agents for future use in human cancer patients. Trials conducted by the COTC are pharmacokinetically and pharmacodynamically rich with the product of this work directly integrated into the design of current human Phase I and II clinical trials. Our trials are carried at COTC member institutions, which currently include twenty sites.

All veterinary universities that met the established criteria have been invited to join the Comparative Oncology Trial Consortium.

For more information regarding the Comparative Oncology Trials Consortium, please contact Christina Mazcko

Added by Mazcko, Christina (NIH/NCI) [E] , last edited by Cawley, Jacob on Apr 16, 2015 19:19